Harvard Mark I

Harvard Mark I
Closeup of input/output and control readers
Also known asIBM Automatic Sequence Controlled Calculator (ASCC)
DeveloperHoward Aiken / IBM
Release dateAugust 7, 1944; 80 years ago (1944-08-07)
Power5 hp (3.7 kW)
Dimensions
  • 816 cu ft (23.1 m3):
  • Width: 51 ft (16 m)
  • Height: 8 ft (2.4 m)
  • Depth: 2 ft (0.61 m)
Mass9,445 lb (4,284 kg)
SuccessorHarvard Mark II
The left end consisted of electromechanical computing components.
The right end included data and program readers, and automatic typewriters.

The Harvard Mark I, or IBM Automatic Sequence Controlled Calculator (ASCC), was one of the earliest general-purpose electromechanical computers used in the war effort during the last part of World War II.

One of the first programs to run on the Mark I was initiated on 29 March 1944[1] by John von Neumann. At that time, von Neumann was working on the Manhattan Project, and needed to determine whether implosion was a viable choice to detonate the atomic bomb that would be used a year later. The Mark I also computed and printed mathematical tables, which had been the initial goal of British inventor Charles Babbage for his analytical engine in 1837.

According to Edmund Berkeley, the operators of the Mark I often called the machine "Bessy, the Bessel engine", after Bessel functions.[2]

The Mark I was disassembled in 1959; part of it was given to IBM, part went to the Smithsonian Institution, and part entered the Harvard Collection of Historical Scientific Instruments. For decades, Harvard's portion was on display in the lobby of the Aiken Computation Lab. About 1997, it was moved to the Harvard Science Center. In 2021, it was moved again, to the lobby of Harvard's new Science and Engineering Complex in Allston, Massachusetts.[3]

  1. ^ Cohen (2000), p. 164.
  2. ^ Berkeley, Edmund Callis. Giant Brains, or, Machines That Think (Classics To Go) (p. 6). Otbebookpublishing. Kindle Edition.
  3. ^ Powell, Alvin (July 23, 2021). "Harvard's Mark 1 finds its new home". Harvard Gazette. Retrieved August 17, 2023.